Rezil
Product Images NDC 76468-121

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Rezil (NDC 76468-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Toqara, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rezil Product Label (Toqara Rezil1 .25)

REZIL Pain Relief Lotion Roll-On label showing the product name, its use for penetrating pain relief for arthritis, strains, sprains, and bruises, and the manufacturer Toqara, Inc. The net content indicated is 0.25 fluid oz. (7.4 mL), with the provided lot number and contact details.*

FDA Label Image

Rezil Back Label (Toqara Rezil1 .25back)

Drug Facts panel for REZIL Pain Relief Lotion Roll-On showing active ingredient Capsaicin 0.025% as a topical analgesic. It includes uses for minor aches and pains, warnings about external use only, directions for use in adults and children over 6, inactive ingredients, and manufacturer details for Toqara, Inc. A barcode and lot number are also present.*

FDA Label Image

Rezil Front Label (Toqara Rezil1 .25front)

REZIL Pain Relief Lotion Roll-On label shows the product name in bold red letters, indicating it is a pain relief lotion in a roll-on format. The text highlights penetrating pain relief for arthritis, strains, sprains, and bruises. The label notes it is a handy pocket or purse-sized roll-on with a net volume of 1/4 fluid ounce (7.4 ml) and includes the NDC number 76468-121-01. Manufactured by Toqara, Inc.*

FDA Label Image

Rezil Label (Toqara Rezil 1)

Drug Facts panel for REZIL Pain Relief Lotion Roll-On by Toqara, Inc. Lists active ingredient Capsaicin 0.025% as a topical analgesic. Provides uses for temporary relief of minor aches and pains of muscles and joints linked to arthritis, strains, sprains, and bruises. Includes warnings for external use, avoidance of eyes, and instructions for application 3-4 times daily on affected areas. Also lists inactive ingredients and contact information for questions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.